Minsoo Chi

Partner

2022 - Current

Spider Capital is a San Francisco-based seed-stage enterprise/B2B venture capital firm focused on the digital transformation of industries.

Principal

2020 - 2022

Senior Associate

2018 - 2020

Board Director

2023

Castellum's mission is to democratize financial crime compliance.

Investor

2022

Velt's mission is to make the web more collaborative.

Board Observer

2021

Cyble's mission is to protect organizations and governments from external and internal cyber threats.

Board Observer

2020

Klir's mission is to help water utilities make water safer.

Board Observer

2019

Smartex's mission is to empower factories to produce with zero waste and transparency.

Associate

2016 - 2018

Responsibilities: Market analysis, investment analysis, deal diligence Primary Focus: Evaluate investment opportunities for growth stage venture backed companies. Significant focus on digital health and enterprise software investment opportunities. Firm Description: With more than $1B under management, ngp capital (www.ngpcap.com) specializes in growth stage investing seeking entrepreneurs building intelligent devices and services connecting everybody and everything. The firm offers market insight, support, a deep network and a global reach spanning the United States, Europe, India and China.

Senior Analyst

2016 - 2016

Senior Associate Consultant

2015 - 2016

Equipment component manufacturer - US Go-To-Market Strategy for a PE Portfolio Company (October 2015 – January 2016) Primary focus: Understand the best way to employ direct sales and channel partners against a complex matrix of customer types and use cases to improve sales growth. First 3 weeks on building fact base. Subsequent 3 weeks on designing GTM model. Last 4 weeks on implementation. M&A Integration Toolkit Development - Internal IP Case (July 2015 – September 2015) Primary focus: Worked with a third party software vendor to develop Bain proprietary software toolkit for future Bain M&A integration support cases.

Associate Consultant

2013 - 2015

Life Sciences Company – Growth Strategy (March 2015 – July 2015) Wrote consulting project proposal and subsequently staffed on this case after winning the proposal. Primary focus: (1) Understand 50 product lines and how each product line is linked, in terms of customer, capability, and cost-sharing (2) Evaluate which areas to invest and divest (3) Formulate alternate corporate strategy options. Private Equity Group (April 2014 – December 2014) Worked with marquee PE firms on eight commercial due diligence projects on target companies in various markets: (1) fire suppression, (2) food service distribution, (3) premium activewear, (4) (5) women’s apparel, (6) home infusion therapy, (7) O&G equipment (8) slip-resistant shoes. Life Sciences Companies – M&A Integration Management Office (August 2013 – April 2014) Developed and refined headcount trackers, which are Excel-based user-intuitive models used by clients to track headcount changes and calculate financial impact, for all 30 workstreams.